Copyright
©The Author(s) 2020.
World J Transplant. May 29, 2020; 10(5): 117-128
Published online May 29, 2020. doi: 10.5500/wjt.v10.i5.117
Published online May 29, 2020. doi: 10.5500/wjt.v10.i5.117
Table 3 Donor demographics and graft variables based on macrosteatosis
| Characteristic | < 30% | ≥ 30% | P value | |
| Donor macrosteatosis | ||||
| Cohort | n (%) | 94 | 5 | |
| Age/yr | Median (range) | 45 (6-78) | 28 (21-52) | 0.21 |
| Gender/male | n (%) | 51 (55) | 2 (40) | 0.50 |
| Warm ischemia time/min | Median (range) | 29 (24-79) | 32 (28-37) | 0.60 |
| Cold ischemia time/min | Median (range) | 265 (129-453) | 307 (248-422) | 0.06 |
| Graft | ||||
| Macrosteatosis | Median % (range) | 0 (0-10%) | 30 (30-40%) | |
| Microsteatosis | Median % (range) | 0 (0-100%) | 50 (0-70%) | 0.001c |
- Citation: Núñez K, Hamed M, Fort D, Bruce D, Thevenot P, Cohen A. Links between donor macrosteatosis, interleukin-33 and complement after liver transplantation. World J Transplant 2020; 10(5): 117-128
- URL: https://www.wjgnet.com/2220-3230/full/v10/i5/117.htm
- DOI: https://dx.doi.org/10.5500/wjt.v10.i5.117